Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Analysis of daily reproduction rates of COVID-19 using Current Health Expenditure as Gross Domestic Product percentage (CHE/GDP) across countries

Kayode Oshinubi, Mustapha Rachdi, Jacques Demongeot
doi: https://doi.org/10.1101/2021.08.27.21262737
Kayode Oshinubi
1Laboratory AGEIS EA 7407, Team Tools for e-Gnosis Medical & Labcom CNRS/UGA/OrangeLabs Telecom4Health, Faculty of Medicine, University Grenoble Alpes (UGA), 38700 La Tronche, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mustapha Rachdi
1Laboratory AGEIS EA 7407, Team Tools for e-Gnosis Medical & Labcom CNRS/UGA/OrangeLabs Telecom4Health, Faculty of Medicine, University Grenoble Alpes (UGA), 38700 La Tronche, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacques Demongeot
1Laboratory AGEIS EA 7407, Team Tools for e-Gnosis Medical & Labcom CNRS/UGA/OrangeLabs Telecom4Health, Faculty of Medicine, University Grenoble Alpes (UGA), 38700 La Tronche, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Jacques.Demongeot{at}univ-grenoble-alpes.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Impact and severity of coronavirus pandemic on health infrastructure vary across countries. We examine the role percentage health expenditure plays in various countries in terms of their preparedness and see how countries improved their public health policy in the first and second wave of the coronavirus pandemic;

Methods We considered the infectious period during the first and second wave of 195 countries with their Current Health Expenditure as Gross Domestic Product percentage (CHE/GDP). Exponential model was used to calculate the slope of the regression line while the ARIMA model was used to calculate the initial autocorrelation slope and also to forecast new cases for both waves. The relationship between epidemiologic and CHE/GDP data was used for processing ordinary least square multivariate modeling and classifying countries into different groups using PC analysis, K-means and Hierarchical clustering;

Results Results show that some countries with high CHE/GDP improved their public health strategy against virus during the second wave of the pandemic;

Conclusions Results revealed that countries who spend more on health infrastructure improved in the tackling of the pandemic in the second wave as they were worst hit in the first wave. This research will help countries to decide on how to increase their CHE/GDP in order to tackle properly other pandemic waves of the present Covid-19 outbreak and future diseases that may occur. We are also opening up a debate on the crucial role socio-economic determinants play during the exponential phase of the pandemic modelling.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding sources

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No IRB nor ethics committee was necessary, because the data used are all coming from public databases

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Kayode.Oshinubi{at}univ-grenoble-alpes.fr, Mustapha.Rachdi{at}univ-grenoble-alpes.fr, Jacques.Demongeot{at}univ-grenoble-alpes.fr

Data Availability

All the data are coming from public databases

  • Abbreviations

    ARIMAF
    Opposite autocorrelation slope for first wave
    ARIMAS
    Opposite autocorrelation slope for second wave
    SecondR
    Maximum R0 for second wave from [3]
    SecondD
    Deterministic R0 for second wave from [2]
    FirstwaveR
    Maximum R0 for first wave from [3]
    FirstwaveD
    Deterministic R0 for second wave from [2]
    CHE/GDP
    Current Health Expenditure as Gross Domestic Product percentage [1]
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted August 29, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Analysis of daily reproduction rates of COVID-19 using Current Health Expenditure as Gross Domestic Product percentage (CHE/GDP) across countries
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Analysis of daily reproduction rates of COVID-19 using Current Health Expenditure as Gross Domestic Product percentage (CHE/GDP) across countries
    Kayode Oshinubi, Mustapha Rachdi, Jacques Demongeot
    medRxiv 2021.08.27.21262737; doi: https://doi.org/10.1101/2021.08.27.21262737
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Analysis of daily reproduction rates of COVID-19 using Current Health Expenditure as Gross Domestic Product percentage (CHE/GDP) across countries
    Kayode Oshinubi, Mustapha Rachdi, Jacques Demongeot
    medRxiv 2021.08.27.21262737; doi: https://doi.org/10.1101/2021.08.27.21262737

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Health Economics
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)